3Radical, the team behind Voco – an engagement platform for brands and consumers – has raised £3m.
Investors into the company, founded by UK tech entrepreneurs David Eldridge and Mike Talbot (the team behind Alterian, which sold for $100m), include fund manager David Newton and Christopher McCann.
3Radical first launched in South East Asia in 2014 and the UK and Australia the following year.
The raise will help support its growth and expansion into existing and new markets.
Eldridge, one of the co-founders, said he was delighted with the support from investors and the “continued growing appetite of brands around the world”.
“The future holds exciting opportunities for us to continue our rapid growth in the UK, Asia Pacific and – in time – the US. We look forward to driving continued innovation with both our existing and new customers, supported by this recent funding round and a hugely strengthened leadership team.”
The dos and don’ts of crowdfunding
“Our company vision is to bring the kind of exciting engagement and emotional connection we get when communicating with our friends using day to day social media platforms – to business. Our award-winning Voco software platform enables brands to create interactive, rewarding digital content and deliver it via the right channels to individuals – whether they be consumers, employees or citizens.
“Our technology is enabling brands to change the way their messages are communicated to motivate response and build true ongoing engagement. From flat emails, short-lived apps and one size fits all websites to relevant, interactive, online experiences which further build connection and brand affinity across the engagement journey and most importantly, on the audiences’ terms,” concluded the serial entrepreneur.
Alongside the funding, 3Radical is also announcing a series of hires to its management team.
David Newberry, an experienced CMO and author, will be joining as chief marketing officer.
Rachel Swann will join the company as European commercial direction, coming from a senior commercial role at HIVE.